Device type · QHJ
Sensor, Glucose, Implanted, Non-Adjunctive Use
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
QHJ
Clinical Chemistry
Device class
Class III
FDA decisions since 2015
3
510(k), De Novo and PMA
Adverse event reports
538
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Sensor, Glucose, Implanted, Non-Adjunctive Use
- Product code
- QHJ
- Device class
- Class III
- Review panel
- Clinical Chemistry
- FDA record
- Classification database entry for QHJ
Latest FDA decisions
- Eversense® E3 Continuous Glucose Monitoring (CGM) SystemPMA supplement
P160048-S021 · Decided Mar 29, 2023 · 180 days after receipt · Panel Track
Device type: Sensor, glucose, implanted, non-adjunctive use (QHJ) · Laboratory Medicine & Pathology
- Eversense® E3 Continuous Glucose Monitoring SystemPMA supplement
P160048-S016 · Decided Feb 10, 2022 · 498 days after receipt · Panel Track
Device type: Sensor, glucose, implanted, non-adjunctive use (QHJ) · Laboratory Medicine & Pathology
- Eversense Continuous Glucose Monitoring SystemPMA supplement
P160048-S006 · Decided Jun 6, 2019 · 192 days after receipt · Panel Track
Device type: Sensor, glucose, implanted, non-adjunctive use (QHJ) · Laboratory Medicine & Pathology
Reports received
538
Received Nov 1, 2025 to Nov 20, 2026. Includes 2 of another or unstated type.
Malfunction reports
351
65% of reports
Injury reports
185
34% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 12 | 31 | 0 | 0 |
| Jan 24 | 65 | 31 | 0 | 0 |
| Feb 24 | 50 | 27 | 0 | 0 |
| Mar 24 | 117 | 70 | 0 | 0 |
| Apr 24 | 21 | 42 | 0 | 0 |
| May 24 | 37 | 41 | 0 | 0 |
| Jun 24 | 22 | 27 | 0 | 0 |
| Jul 24 | 23 | 37 | 0 | 0 |
| Aug 24 | 21 | 32 | 0 | 0 |
| Sep 24 | 24 | 33 | 0 | 0 |
| Oct 24 | 30 | 35 | 0 | 0 |
| Nov 24 | 25 | 45 | 0 | 0 |
| Dec 24 | 25 | 35 | 0 | 0 |
| Jan 25 | 22 | 30 | 0 | 0 |
| Feb 25 | 24 | 14 | 0 | 0 |
| Mar 25 | 27 | 20 | 0 | 0 |
| Apr 25 | 25 | 24 | 0 | 0 |
| May 25 | 23 | 30 | 0 | 0 |
| Jun 25 | 32 | 28 | 0 | 0 |
| Jul 25 | 56 | 20 | 0 | 0 |
| Aug 25 | 44 | 31 | 0 | 0 |
| Sep 25 | 32 | 19 | 0 | 0 |
| Oct 25 | 35 | 15 | 0 | 0 |
| Nov 25 | 23 | 13 | 0 | 0 |
| Dec 25 | 24 | 24 | 0 | 0 |
| Jan 26 | 12 | 18 | 0 | 0 |
| Feb 26 | 37 | 12 | 0 | 0 |
| Mar 26 | 14 | 25 | 0 | 0 |
| Apr 26 | 52 | 27 | 0 | 0 |
| May 26 | 22 | 22 | 0 | 0 |
| Jun 26 | 30 | 9 | 0 | 0 |
| Jul 26 | 31 | 11 | 0 | 0 |
| Aug 26 | 30 | 1 | 0 | 0 |
| Sep 26 | 30 | 11 | 0 | 1 |
| Oct 26 | 46 | 12 | 0 | 1 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Senseonics538
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Imprecision188
- Premature End-of-Life Indicator132
- Adverse Event Without Identified Device or Use Problem85
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions416
- Hypoglycemia26
- Hyperglycemia23
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0251-2020 · Started Sep 18, 2019
Reason given: Eversense Sensors have prematurely stopped functioning due to inadequate hydration of the sensor s glucose-sensing surface
Cause as FDA categorized it: Process control
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.